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AIMS OF THE THESIS 
1. Are astrocytes competent of releasing glutamate by exocytosis? 
     Do astrocytes contain vesicular glutamate transporters (VGLUTs)? 
     Do astrocytes in different brain regions contain VGLUTs? 
     Do single astrocytes contain more than one VGLUT? 
 
2. Are astrocytes competent of releasing GABA by non-exocytotic routs? 
     Do astrocytes contain the Ca2+ activated Cl- channel bestrophin 1? 
INTRODUCTION 
The glutamatergic synapse 
An axon projecting from a nerve cell ends in a convex structure called the terminal or 
the bouton (Kristen and Harris, 2012). The terminal opposes a spine, a convex 
structure projecting from the dendrite belonging to another nerve cell (Kristen and 
Harris, 2012). These two structures are divided by a 20 nm synaptic cleft consisting of 
extracellular matrix (Kristen and Harris, 2012). 
Synaptic vesicles of 40 nm in diameter are located within the terminal (Kristen and 
Harris, 2012). The vesicles express vesicular glutamate transporter 1 (VGLUT1) or 
vesicular glutamate transporter 2 (VGLUT2) in their membrane, depending of the 
brain area (Fremeau et al, 2001). VGLUT1 (described in more detail later) and 
VGLUT2 (not discussed here) transport glutamate into the vesicles by an 
electroctrochemical gradient made by an ATP driven proton pump (Fremeau et al, 
2001). Also located in the vesicle membrane is synaptobrevin and synaptotagmin 
(Südhof, 2008). Together with SNAP-25 and syntaxin, which are both located on the 
presynaptic membrane, these four proteins are essential for attaching synaptic vesicles 
to the presynaptic membrane and exocytosis of glutamate (Südhof, 2008; Südhof, 
2012).  
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Figure 1: Exocytotic machinery-synaptotagmin, synaptobrevin , syntaxin and SNAP-25 
Exocytosis of glutamate is initiated by arrival of an action potential in the terminal. 
The action potential activates voltage-dependent calcium channels (VDCC) located in 
the presynaptic membrane (Dunlap et al, 1995). Opening of VDCC leads to an influx 
of calcium that binds to the C2 region of synaptotagmin, which will then interact with 
the phospholipids in the presynaptic membrane and induce assembly of the SNARE 
proteins (Südhof, 2008). In turn, this will accomplish fast and synchronous vesicle 
exocytosis of glutamate into the synaptic cleft (Chapman, 2008; Pang and Südhof, 
2010; Südhof, 2004). Neurons lacking synaptotagmin will still be able to exocytose 
neurotransmitters, although it will be slow and asynchronous (Chapman, 2008; Pang 
and Südhof, 2010; Südhof, 2004). 
Exocytosed glutamate will diffuse over the synaptic cleft and bind to glutamate 
receptors on the membrane of the dendritic spine facing the terminal (the postsynaptic 
membrane).  The glutamate receptors located on the postsynaptic membrane are 
mainly of the AMPA and the NMDA receptor types (Dingledine et al, 1999). The 
AMPA receptor is a fast executing potassium and sodium channel (Dingledine et al, 
1999). The influx of sodium leads to a fast excitatory postsynaptic potential (EPSP). 
The NMDA receptor is a sodium and calcium channel (Dingledine et al, 1999). In 
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contrast to the AMPA receptor, the NMDA receptor only opens when the membrane 
is depolarized and need binding of a coagonist on the glycin binding site for 
maximum effect (Dingledine et al, 1999).  This preconditioning of the membrane to 
open the NMDA receptor channel and the fact that opening of the channel increase 
the intracellular level of calcium, which also can function as a second messenger, 
indicates that activation of NMDA receptor have other consequences than just induce 
EPSP (Dingledine et al, 1999).  
The EPSP causes a depolarization of the membrane of the spine, but one EPSP is 
rarely enough to mediate an action potential. However, if several EPSP reach the 
same dendrite within the time its membrane reach the resting potential, either through 
high frequent exocytosis from one terminal (temporal summation) or single 
exocytosis from many terminal facing different spines on the same dendrite (spatial 
summation) the dendritic membrane may be depolarized above the threshold (Yuste, 
2013; Takagi, 2000). This will open voltage gated sodium channels and give an action 
potential. 
At a membrane potential of 55 mV the sodium equilibrium is reached and sodium 
channels inactivates (Bean, 2007). The reduced permeability to sodium and the 
prolonged opening of voltage dependent potassium channels due to the raised voltage 
will repolarize the membrane and bring it back to resting potential (Bean, 2007).  
If only an EPSP is induced the duration of the EPSP is dependent of desensitization of 
the receptor channels. AMPA receptors are desensitized more rapidly than NMDA 
receptors, but within the two groups of receptor there are variations due to the 
compositions of subunits (Dingeldine et al, 1999). 
The tripartite synapse 
A concave astrocytic process enclaves the terminal and the adjacent spine. Together 
this unit is called the tripartite synapse (Araque et al, 1999). 
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Figure 2: 
Electromicrograph of 
the tripartate synapse- 
terminal (T), spine (S) 
and astrocyte (A) 
Astrocytes have 
traditionally been 
regarded to play a 
“passive” role in 
synaptic transmission. 
However, during the 
last years many 
important functions 
for neuron-astrocyte 
signaling have been discovered. After synaptic release glutamate diffuses passively 
away from the synaptic cleft to the extrasynaptic space (Danbolt, 2001). To maintain 
an efficient diffusion of glutamate it is important to keep a low concentration of 
glutamate in the extrasynaptic space (Danbolt, 2001). The only way to do this is by an 
active glutamate uptake (Danbolt, 2001). This is mainly accomplished by glutamate 
transporters located in the membrane of astrocyte processes surrounding the synapse, 
the perisynaptic astrocyte processes (Danbolt, 2001). It is important to keep the 
intrasynaptic and extrasynaptic concentration of glutamate low both to avoid 
sustained glutamate receptor activation (keeping “signal/noise ratio” high) and toxic 
effects of high glutamate concentrations (Danbolt, 2001). The most abundant plasma 
membrane glutamate transporter in astroglial cells in the hippocampus is GLT 
(EAAT2) and in the cerebellum GLAST (EAAT1) (Danbolt, 2001). Within the 
astrocyte the glutamate is either converted to glutamine through glutamine synthetase 
or enter the Krebs cycle via conversion to α-ketoglutarat by glutamate dehydroxylase 
(Danbolt, 2001). Glutamine is transported out of the astroglial cell, taken up by the 
terminal and either converted to glutamate or used as an energy substrate (Danbolt, 
2001). 
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During the repolarization of the neuronal elements of the synapse there will be an 
increase in extracellular potassium concentration. In order to keep a constant 
potassium concentration astroglial cells take up the excess of potassium ions (Walz, 
2000). 
The astroglial glutamate uptake and the potassium uptake are established properties of 
these cells. Although these properties are vital to the synaptic function, they only have 
an indirect impact on synaptic signaling. Subsequently the astroglial cell was regarded 
as a non-signaling cell for many years. The last 20 years it has been revealed that 
astroglial cells both respond to neuronal signaling and release transmitter substances 
referred to as gliotransmittors. Thereby the name: the tripartite synapse. Many release 
mechanisms have been suggested, only a few will be mentioned here, with the 
emphasis on astroglial exocytosis of glutamate. 
Glutamate release from astrocytes 
Exocytosis 
To initiate a calcium dependent fusion of an astrocytic vesicle with the plasma 
membrane, the astrocyte is dependent on a calcium sensitive protein. In neurons 
synaptotamgin I and II are the main proteins that initiate exocytosis of synaptic 
vesicles (Südhof, 2004). However, different studies show different results concerning 
the main subtype of synaptotagmin in astrocytes. The conclusion of most studies, both 
in cultures and in the intact brain is that synaptotagmin IV is expressed by astrocytes 
(Crippa et al, 2006; Malarkey and Parpura, 2011; Potokar et al, 2008; Zhang et al, 
2004; Stenovec et al, 2007). However, other subtyper, eg synaptotagmin I, has also 
been detected in astrocytes (Maienschein et al, 1999; Colombo and Bentham, 2006). 
To be noted is that Mittelsteadt et al (2009) showed that different astrocytes express 
different subtypes of synaptotagmin, which might explain some of the discrepancy in 
the results. Whether synaptotagmin IV is a calcium sensor that can mediate calcium 
dependent exocytosis is a matter of debate. 
 
When synaptotagmin binds calcium it initiates vesicular fusion and assembly of the 
SNARE complex, which is necessary to complete the fusion. Synaptobrevin, which is 
attached to vesicles, is one of the units in the SNARE complex. In cultured astrocytes 
both synaptobrevin 2 and 3 have been found (Mothet et al, 2005; Crippa et al, 2006; 
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Zhang et al, 2004b), while most in vivo studies have shown synaptobrevin 3, but no 
synaptobrevin 2 (Chilcote et al, 1995; Bezzi et al, 2004; Schubert et al, 2011).   
The proteins of the SNARE complex located in the plasma membrane, syntaxin and 
SNAPs, has also been detected in astrocytes. Syntaxin 1 is shown to be present in 
both culture studies (Parpura et al, 1995; Calegari et al, 1999), as well as in one in 
vivo study (Schubert et al, 2011) of astrocytes.  
The last component of the ternary SNARE complex is SNAP. Like in neurons some 
culture studies have localized SNAP-25 in astrocytes (Jeftinija et al, 1997; 
Maienschein et al, 1999), while other culture studies and in vivo studies found its 
homologue SNAP-23, but not SNAP-25 (Crippa et al, 2006; Yasuda et al, 2011; 
Schubert et al, 2011; Hepp et al, 1999). An explanation to this discrepancy might be 
that astrocytes express SNAP-25 abundantly when cultured, in contrast to astrocytes 
in intact tissue, which only express small amount of SNAP-25, but considerable 
amount of SNAP-23 (Wilhelm et al, 2004).  
Like in neurons, exocytosis of glutamate by astrocytes is initiated by a cytosolic rise 
in calcium. The main mechanism of cytosolic calcium increase in astrocytes is 
thought to be through binding of glutamate to metabotropic glutamate receptor 
(mGlurR) type 1 or 5, or to purinergic ATP receptors (eg metabotropic P2Y2 
receptors) (Verkhratsky et al, 1998). These metabotropic receptors are G-protein 
coupled and the G-protein activates phospholipase C, which generates inositol (1,4,5)- 
triphosphate (InsP3) (Verkhratsky et al, 1998). The InsP3 binds to InsP3 receptors on 
the endoplasmic reticulum (ER) and subsequently release stored calcium from the ER 
(Verkhratsky et al, 1998). Although this mechanism is well described there are several 
other routes for calcium increase in the astrocyte cytosol: 
1. Ionotropic receptors 
The AMPA (lacking GluR2) and NMDA glutamate receptors, as well as the 
purinoceptor 2x (P2x), are shown to be located in the plasma membrane of the 
astrocyte and by binding of glutamate and ATP, respectively, could lead to an 
influx of extracellular calcium to the cytosol (Verkhratsky et al, 1998). 
 
2. Voltage gated calcium channels (VGCC)  
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One studie have indicated the presence of VGCC in the plasma membrane of 
the astrocyte (Latour et al, 2003). Although astrocytes do not form action 
potentials, studies have shown that high extracellular potassium 
concentrations, lead to a depolarization of the astrocyte and opening of 
VGCCs (Yaguchi and Nishizaki, 2010). It has also been suggested that the 
influx of extracellular sodium through ionotropic channels may lead to a 
depolarization of the retinal glial cell and opening of VGCCs (Linnertz et al, 
2011). So far the VGCCs are not found in the Bergman glia cells (Verkhratsky 
et al, 1998).  
 
3. Sodium-calcium exchanger (NCX) 
The NCX is located in the plasma membrane of astrocytes and is working 
bidirectional (Reyes et al, 2012; Paluzzi et al, 2007). The direction of the NCX 
is dependent of the trans-membrane sodium gradient and the plasma 
membrane potential. An increase of cytosolic sodium, like when ionotropic 
receptors are activated, will lead to an inward calcium current and transport of 
sodium to the extracellular space (Reyes et al, 2012; Paluzzi et al, 2007). 
 
4. Mitochondrial regulation of cytosolic calcium 
Mitochondria have the ability both to take up cytosolic calcium through 
uniporters and to release calcium through sodium-calcium exchangers and 
permeability transient pores (Demaurex et al, 2009). Glial mitochondria have 
been shown to both limit and enhance the calcium level in astrocytes (Boitier 
et al, 1999; Reyes and Parpura 2008). Whether glial mitochondria release 
calcium and thereby initiate glutamate release or take up calcium to limit 
glutamate release is unclear.  
VGLUTs 
When I started my PhD project it was known that vesicles, ranging from about 30 nm 
(synaptic-like microvesicles (SLMV)) (Bezzi et al, 2004; Jourdain et al, 2007; 
Stigliani et al, 2006), 30 nm-110nm (Crippa et al, 2006), 50-170 nm (Stenovec et al, 
2007; Xu et al, 2007) to over 300 nm (Chenet al, 2005), and large dense core vesicles 
(Calegari et al, 1999; Coco et al, 2003) could be located in astrocytes. Such vesicles 
represent the glial organelles thought to exocytose gliotransmitters. In addition, 
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lysosomes were shown to undergo exocytosis glutamate (Jaiswal et al, 2007; Li et al, 
2008).  
Moreover, the three vesicular glutamate transporters, VGLUT1, VGLUT2 and 
VGLUT3 were all located in astrocytes (Stenovec et al, 2007; Montana et al, 2004; 
Kreft et al, 2004; Anlauf and Derouiche 2004, Bezzi et al 2004; Zhang et al 2004b, 
Stigliani et al 2006; Potokar et al, 2009; Fremeau et al, 2002; Crippa et al, 2006; Ni et 
al 2009; Liu et al, 2011; Martineau et al, 2013; Cali et al, 2014).  Of these, one 
electron microscopical study has revealed VGLUTs in association with astrocytic 
vesicles in intact brain tissue (Bezzi et al, 2004). The latter study showed that 
VGLUT1 and VGLUT2 positive SLMVs were located in glial processes enclosing 
glutamatergic synapses (Bezzi et al, 2004). Further corroborating the idea that 
VGLUTs are localized in astrocytes was that functional studies using the VGLUT 
inhibitors trypan blue and rose bengal, as well as the proton pump inhibitor 
bafilomycin A reduced glutamate release from astrocytes (Liu et al, 2011; Montana et 
al, 2004; Zhang et al, 2004b). However studies on cultured astrocytes from cortex and 
hippocampus have shown colocalization of VGLUT1 with lysosomal markers (Li et 
al, 2008). 
Common for all VGLUTs are that they have channel like properties connected to 
glutamate transport (Tabb et al, 1992). The driving force for transporting glutamate 
into vesicles by VGLUTs is the high intravesicular proton level. Although it is 
important to emphasize that it is not the pH gradient itself, but the electrical gradient 
across the vesicle membrane, which is made by the high proton level, that initiate 
glutamate transport into to the vesicle. The pH gradient is accomplished by a H+-
ATPase which create a proton influx to the interior of the vesicle (Naito and Ueda, 
1985). Besides being dependent upon ATP, the efficiency of VGLUT1 seems to be 
affected by the cytosolic chloride level (Tabb et al, 1992). 
VGLUT1 
The VGLUT1 protein consists of 560 amino acids and has 6-8 membrane spanning 
segments (Ni et al, 1994). In adults VGLUT1 is found in neuronal terminals mainly in 
the cerebral cortex, cerebellar cortex and hippocampus. VGLUT1 is also present in 
more central nuclei, such as thalamus, hypothalamus and striatum, whereVGLUT2 is 
the dominant VGLUT, as well as amygdala where VGLUT1 and VGLUT2 is equally 
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present (Fremeau et al, 2001). At birth neuronal VGLUT1 is absent or at very low 
levels in rats and mice (Boulland et al, 2004; Fremeau et al, 2004). During postnatal 
development VGLUT1 increases progressively until adulthood (Boulland et al, 2004; 
Fremeau et al, 2004). 
Among the VGLUTs, VGLUT1 is the least glutamate sensitive with a Km of 3,4mM 
(Herzog et al, 2001). However, VGLUT1 has the fastest kinetics with a Vmax of 500 
pmol/mg (Herzog et al, 2001). An increase in expression of VGLUT1 in neurons has 
shown increased release of glutamate from each vesicle (Wojcik et al, 2004). 
Overexpressing VGLUT1 in astrocytes has no effect on their exocytotic glutamate 
release, which might be due to the rather high Km value of VGLUT1 and the rather 
low glutamate level in the astrocytes (Ni amd Parpura, 2009).  However, 
overexpression of VGLUT3 in astrocytes, as well as increasing cytosolic glutamate 
levels, caused increased glutamate release (Ni and Parpura, 2009). 
Mice lacking VGLUT1 show no phenotypic differences from their littermates the first 
2 weeks after birth (Wojick et al, 2004; Fremeau et al, 2004). After two weeks of age 
the VGLUT1 knock out mice fed poorly and they started to die after 3 weeks of age, 
unless they were separated from their littermates and supplied with food and water 
(Fremeau et al, 2004). If they survived the critical period between 3-4 weeks after 
birth they could live for months, but showed a phenotype of blindness, incoordination 
and enhanced startle response (Fremeau et al, 2004). 
VGLUT3 
VGLUT3 is structurally highly similar to VGLUT1 (72,5%). It consists of 589 amino 
acids and has eight membrane spanning segments (Takamori et al, 2002). At the 
protein level VGLUT3 is localized in the hippocampus (pyramidal cell layer, dentate 
gyrus, granule cell layers, between stratum radiatum and lacunosum moleculare), 
cerebral cortex, striatum, amygdala, cerebellum, nucleus accumbens, thalamus, 
hypothalamus, substantia nigra, brain stem and inner hair cells (Herzog et al, 2004; 
Fremeau et al, 2002; Boulland et al, 2004; Seal et al, 2008). Unlike VGLUT1, 
VGLUT3 is frequently colocalized with other vesicular transporters such as the 
vesicular GABA transporter (VGAT), vesicular monoamine transporter (VMAT) and 
vesicular acetylcholine transporter (VAChT). For instance, in the hippocampus 
(pyramidal cell layer and granular cell layer) VGLUT3 colocalizes with a 
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subpopulation of GABAergic terminals, although not all VGLUT3 positive structures 
were GABAergic (Herzog et al, 2004; Fremeau et al, 2002; Boulland et al, 2004). In 
the striatum VGLUT3 has been found in cholinergic neurons (Herzog et al, 2004; 
Boulland et al, 2004). VGLUT3 has also been found at non synaptic sites such as 
Bergman glia cells in the cerebellum, neuronal axons from the raphe nuclei and 
dendrites in the striatum (Fremeau et al, 2002; Boulland et al, 2004). The level of 
VGLUT3 increases after birth, but no regional changes are seen (Boulland et al, 
2004), although it is observed transient expression of VGLUT3 in cell bodies of the 
paraventricular zone, terminal-like structures of the cerebellar nuclei and terminal-like 
structures in the paraolivary nucleus (Boulland et al, 2004). 
VGLUT3 has similar properties considering glutamate transport as VGLUT1 
(Takamori et al, 2002; Schäfer et al, 2002; Gras et al, 2002). VGLUT3 has a Vmax of 
20,3pmol/mg and a Km ranging from 0,52mM to 1,5mM making VGLUT3 the 
slowest and most glutamate sensitive of the VGLUTs (Gras et al, 2002; Fremeau et al, 
2002). In contrast to VGLUT1, increased expression of VGLUT3 in astrocytes 
elevates glutamate release from astrocytes (Ni and Parpura, 2009). This might be due 
to the rather low Km and the low Vmax of VGLUT3. Since VGLUT3 has low Km it 
could be sensitive to even the low concentrations of glutamate in the astrocytes. Since 
VGLUT3 has a low Vmax the existing level of VGLUT3 in astrocytes is probably not 
sufficient to fill the vesicles with glutamate.  
Knockout VGLUT3 mice suffer from total hearing loss (Seal et al, 2008; Ruel et al, 
2008). The hearing loss is due to the loss of vesicle filling with glutamate in the inner 
hair cells (Seal et al, 2008; Ruel et al, 2008), leading to an impairment of 
neurotransmission at the inner hair cell afferent terminals, where VGLUT3 is the only 
VGLUT present (Seal et al, 2008; Ruel et al, 2008). In coherence with this, one study 
has revealed gene mutations in the VGLUT3 gene in humans suffering from deafness 
(Ruel et al, 2008). 
Non-vesicular release of glutamate from astrocytes 
Volume regulated anion channels (VRAC) are, among other types of cell, localized in 
the cell membrane of astrocytes and were initially found to release anions due to cell 
swelling under pathological conditions (Kimelberg et al, 2006). VRACs have also 
been shown to release anions, like glutamate, following calcium rise in astrocytes 
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under physiological conditions (Takano et al, 2005; Liu et al, 2009). In these two 
studies the calcium rise was induced by P2Y ATP receptors and bradykinin receptors, 
respectively.  
As mentioned P2X receptors create a calcium influx upon ATP binding to the 
receptors. In addition one study have shown that the P2X receptor also creates an 
efflux of anions like glutamate (Duan et al, 2003).  
Under pathological conditions, like ischemia, astrocytic glutamate transporters located 
in the plasma membrane (excitatory amino acid transporters (EAATs) can be reversed 
and thereby release glutamate (Rossi et al, 2000). Unlike other physiological 
mechanisms to release glutamate the reversion of astrocytic glutamate transporters are 
calcium independent. 
Hemichannels in astrocytes have been shown to release gliotransmitters. Among the 
most studied astrocytic hemichannels are connexin 43 and pannexin 1. Connexin 43 
has so far only shown to release glutamate under pathological conditions, i.e. 
independent of intracellular calcium levels (Ye et al, 2003; Spray et al, 2006; Jiang et 
al, 2011). However, pannexin 1 seems to release ATP under physiological conditions 
(Iglesias et al, 2009). In xenopus oocytes pannexin 1 has shown to open in response to 
increased concentrations of cytoplasmic calcium  (Locovei et al, 2005). So far 
pannexin 1 in astrocytes have only been studied considering ATP release, although it 
is likely that pannexin 1 also release glutamate (Malarkey and Parpura 2008). 
GABA release from astroglia 
GABA has been found in Bergman glial cells and hippocampal astrocytes under 
physiological conditions (Le Meur et al, 2012; Gundersen et al, 2001; Blomqvist and 
Broman, 1988). Astroglial GABA can stem from cellular uptake through the GABA 
transporters  (GATs). GAT1 is found in neurons and asroglial cells in many structures 
of the brain, among them hippocampal astrocytes and cerebellar Bergman glial cells 
(Borden 1996; Morara et al, 1996; Yan et al, 1997). GAT3 is also found in the brain, 
although whether GAT3 is found in glial cells in hippocampus and cerebellum is 
disputed (Borden 1996; Ribak et al, 1996). GATs contribute to an increased 
intracellular level of GABA. This, however, will depend on the distance from a 
GABAergic source, for instance a GABAergic terminal, and the efficiency of the 
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GABA metabolizing enzyme GABA-α-ketoglutaric acid aminotransferase (GABA-T) 
within the astroglial cell. An alternative source for intraglial GABA is glial 
production through glutamic acid decarboxylase (GAD). GAD is mainly found in 
GABAergic terminals, but has also been found in hippocampal astrocytes and 
cerebellar Bergman glia cells (Lee et al, 2011; Benagiano et al, 2000). 
Unlike the EAATs, GATs can be reversed also under physiological conditions 
(Richerson and Wu, 2003). Thus, glial cells containing GATs can potentially release 
GABA. One culture study has shown release of GABA through GATs upon AMPA 
stimulation, while a slice study have shown GABA release through GATs induced by 
changes in extracellular GABA concentration (Gallo et al, 1991; Barakat and Bordey, 
2002). Both studies have been done on cerebellar glial cells. GABA can also be 
released through volume sensitive anion channels when P2X7 receptors are activated 
(Wang et al, 2002). Based on the presence of hemichannels in astrocytes and that 
GABA is small enough to pass through a hemichannel, hemichannels could have a 
potential role in the release of GABA, even this is not shown in any study. 
Finally, studies have shown that astrocytes in the stratum radiatum of CA1 
hippocampus and Bergman glia cells in the cerebellum release GABA through the 
calcium sensitive anion channel bestrophin 1 (Lee et al, 2010; Yoon et al 2011). The 
glial release of GABA from these channels lead to tonic inhibition (Lee et al, 2010; 
Yoon et al 2011). The authors found that there was a higher density of GABA positive 
cerebellar astroglial cells than hippocampal astrocytes, proposing that this could 
explain the observed higher level of tonic currents in the cerebellum compared with 
the stratum radiatum in the CA1 hippocampus (Yoon et al 2011). 
Bestrophin 1 
Bestrophin 1 consists of 585 amino acids and forms 4 transmembrane helices, a 
transmembrane reentrant loop and the N- and C-termini within the cytoplasma 
(Tsunenari et al, 2003). Milenkovic et al represented an alternative topology without 
the transmembrane reentrant loop (Milenkovic et al, 2007). The presence of the 
protein in different tissues is sparsely studied. So far the bestrophin 1 protein has been 
found in retinal pigment epithelium (RPE), colon epithelium, kidney epithelium and 
epithelial cells of airways in human and mouse (Marmorstein et al, 2000; Bakall et al, 
2003; Kunzelmann et al, 2009; Soria et al, 2006). Recently, bestrophin 1 was also 
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found in the cerebellum and the hippocampus in the mouse brain (Lee et al, 2010; 
Park et al, 2009). Among other tissues, in both human and mouse, there is high RNA 
expression of bestrophin 1 in the testis (Krämer et al, 2004; Pifferi et al, 2006; Stöhr 
et al, 2002). Few developmental studies on Bestrophin 1 have been done, although 
one study shows that Bestrophin 1 is absent in retinal pigment epithelium cells until 
the mice are 10 days old (Bakall et al, 2003). 
Bestrophin 1 is a chloride channel, where the second transmembrane domain is 
involved in forming the pore (Sun et al, 2001; Tsunenari et al, 2003). The single 
channel conductance of drosophilia Bestrophin 1 is ≈ 2pS (Chien et al, 2006). 
Bestrophin 1 is a calcium activated channel with a Kd of ≈ 210nM calcium (Qu et al, 
2003). Although it resembles the classical calcium activated chloride channels there 
are some important differences. Bestrophin 1 is not voltage dependent and does no 
exhibit outward rectification (Hartzell et al, 2005). Besides calcium, Bestrophin 1 is 
also stimulated by hypoosmotic solutions (Fischermeister and Hartzell, 2005). Since 
hyperosmotic solutions inhibit bestrophin 1, it is proposed that Bestrophin 1 might be 
a type of VRAC (Fischermeister and Hartzell, 2005). There are, however differences, 
for instance the kinetics and the rectification in normosmotic solutions 
(Fischermeister and Hartzell, 2005). Bestrophin 1 is also less sensitive to 
hyposmolarity than VRAC (Fischermeister and Hartzell, 2005). There are also some 
studies indicating that bestrophin 1 is regulated by phosphorylation (Duran et al, 
2013; Duta et al 2006).  
The cellular function of bestrophin 1 is not clear or at least not uniform among cell 
types. In RPE bestrophin 1 has been localized close to the basolateral plasma 
membrane (Marmorstein et al, 2000). Initially it was thought that bestrophin 1 was 
located in the basolateral plasma membrane to mediate chloride release and creating a 
light peak (Marmorstein et al, 2000). Later studies, however, have shown unchanged 
chloride release from the RPE cells when bestrophin 1 is either knocked out or 
mutated (Marmorstein et al, 2006; Zhang et al, 2010). It has therefor been suggested 
that bestrophin 1 is located in the membrane of endoplasmic reticulum close to the 
basolateral membrane in RPE cells working as a counter ion channel for calcium 
release (and reuptake) from the endoplasmic reticulum (Barro-Soria et al, 2010; 
Strauß et al 2012). The calcium released from endoplasmic reticulum activates other 
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chloride channels in the basolateral membrane of RPE (Barro-Soria et al, 2010). In 
epithelial cells of the airways, bestrophin 1 has been shown to be localized in the 
basolateral membrane and function as chloride channels (Duta et al, 2004). 
Mutations in the human bestrophin 1 gene are closely related to Best vitelliform 
macular dystrophy (Marquardt et al, 1998; Petrukhin et al, 1998). The mechanisms of 
how mutations in bestrophin 1 cause this disease are still unclear. Bestrophin 1 
knockout mice do not present any retinal pathology or any other gross pathology, as 
well as they breed normally (Marmorstein et al, 2006). Why there is a discrepancy 
between the bestrophin 1 phenotype of humans and mice is not certain. Mice are, 
however, nocturnal and do not have macula, and therefore it might be difficult to 
compare mice with humans. In addition, mice might have other chloride channels, 
which probably could substitute the functions of bestrophin 1. 
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METHOD 
Immunocytochemistry 
In our studies we used antibodies to localize the proteins of interest. Antibodies 
consist of two heavy and two light chains. At the terminal end of the heavy and light 
chain pair is the paratope. The paratope recognize specific structures. Which 
structures varies among different antibodies. The variability is mainly accomplished 
by loops of β strands refered to as complementarity determining regions (Sela-Culang 
2013).  The ability of antibodies to be designed to recognize specific structures make 
them ideal to visualize cellular proteins. However, some antibodies show cross-
reaction with other epitopes. To reveal any cross-reaction (unspecific binding) we 
controlled our experiments with knockout animals and western blots. Typically, cross-
reacting antibodies label knockout and wild type equally and show more than one 
band on western blot. Other antibodies do not recognize a protein in the tissue even if 
their paratope should recognize a peptide from the protein (Holmseth 2005).  In such 
cases negative tissue labelling needs to be controlled by labelling tissue known to 
contain the proteins or by methods independent of the antibody. 
All experiments included in this thesis were performed on in vivo tissues. This was 
done to avoid exogenous factors that could manipulate the expression of astrocytic 
proteins. Several concerns have been admitted to in vitro studies since they not always 
seem to capture the nature of in vivo tissue (Kimelberg 2000).  
Confocal microscopy 
Crosstalk is a phenomenon where the same laser excites two fluorophores of different 
wavelength and the emitted light are captured in the same picture. To avoid crosstalk 
we chose fluorophores distant in wavelength. Although there are only small amounts 
of VGLUTs in astrocytes we chose fluorophores with wavelength within visible 
range. We also chose appropriate emission filters to make shore we only obtained 
light from one fluorophore. Finally, the signals from the two fluorophores were 
captured sequentially.  
For optimal resolution one should use a pinhole of 1 Airy unit. However, with such a 
narrow pinhole some information will be lost. In our studies we therefor used a 
pinhole of 1,2 Airy unit. Since optics tens to convolute image information this would 
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create out of focus blurres light. To optimize the resolution we deconvolved the 
confocal pictures. Deconvolution would reassure the borders of astrocytes and 
terminals by removing the out of focus blurred light. Image J or Autoquant 
accomplished the deconvolution.  
The confocal pictures are captured by a digital camera producing a picture composed 
of pixels. The size of the pixels applied is crucial for how well the details of the 
structures are preserved in the picture. We therefor applied the pixel size according to 
Nyquist theorem, both in x, y and z axis. 
Immunogold 
Mainly epitopes on the tissue surface are labelled by the immunogold method. That is 
because the Lowicryl HM20 resin is hydrophobic and does not allow antibody 
penetration into the section (Bergersen et al 2008). This will lead to a lower labelling 
density than found in for instance confocal microscopy. However, it will result in a 
more reliable quantification since all epitopes are equally available for binding to the 
antibodies.  
The measurements of VGLUT gold particles are only an indirect value of the actual 
amounts of VGLUT epitopes found in astrocytes. There are two main reasons for this: 
1) The VGLUT antibodies will not attach to all VGLUT epitopes in the tissue. 2) 
Many epitopes will be “hidden” in the section and not reached by any antibodies. The 
fact that we only obtain two-dimensional electron micrographs will not disturb the 
immunogold results. According to Delesse principle the proportion of a compound in 
an area is the same as the proportion in a volume. Since the astrocytic perisynaptic 
processes are cut at different locations more or less of vesicle clusters would be 
present and though more or less epitopes. To avoid that this could give a false mean 
labelling density we obtained many micrographs in each study. However, the fact that 
more or less epitopes are represented in the sections would lead to a wide variation.   
Due to the complex of the primary and the secondary antibody the distance from the 
epitope to the centre of the gold particle will be approximately 30 nm (Bergersen et al, 
2008). This means that the epitope could be anywhere within this distance from the 
centre of the gold particle. It is, however, possible to find out what structure the 
epitope most likely is located on. This is possible by measuring the structure that 
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appear most frequently in the distance of 30 nm from the centre of the gold particle. 
In our case we investigated whether the astrocytes have VGLUT positive vesicles and 
therefor only measured the amount of gold particles that could represent labelling of 
epitopes on vesicles. 
Real time polymerase chain reaction 
In this thesis we used two-step PCR, where cDNA synthesis and the amplification 
occur in two different tubes. Based on the findings in the confocal experiments of 
bestrophin 1 we expected to detect little bestrophin 1 RNA and therefore the two-step 
method was more suitable since it is more sensitive than the one-step method.   
The amount of RNA in the samples was quantified by the standard curve method and 
normalized with the housekeeping gene GAPDH. The standard curve method was 
chosen since we do not know the amplification efficiency of bestrophin 1. We had too 
few animals to statistically analyse whether there was a significant difference in the 
bestrophin 1 RNA signal between bestrophin 1 knockout and wild type. However, in 
all wild type samples the bestrophin 1 RNA level was equal or lower compared to the 
level in the knockout samples, strongly suggesting that the bestrophin 1 signal in the 
wild type brain was at background level. Besides the measurement of the RNA 
amount was important to control the quality of the bestrophin 1 primer. A high level 
bestrophin 1 RNA in the positive control indicates that the primer worked. A low 
level or none bestrophin 1 RNA in the negative control suggests a high selectivity. 
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SUMMARY OF RESULTS 
Paper I 
“VGLUT1 is localized in astrocytic processes in several brain regions” 
In this article we studied the presence of VGLUT1 in astrocytic processes. Using 
confocal microscopy we visualized VGLUT1 labelling within large astrocytic 
processes in the dentate-molecular layers, the stratum radiatum of CA1 hippocampus, 
the frontal cortex, and the striatum. With immunogold cytochemistry we found a 
significant level of VGLUT1 positive gold particles in astrocytic perisynaptic 
processes in the above mentioned brain regions. More than 95% of the VGLUT1 
positive gold particles in astrocytic processes were within 25 nm from the membrane 
of synaptic-like microvesicles. These findings indicate that astrocytes in the studied 
brain regions can acumulate glutamate into microvesicles through of VGLUT1.  
Paper II 
“A distinct set of synaptic-like microvesicles in astroglial cells contain VGLUT3”  
In this article we studied the presence of VGLUT3 in astrocytic processes. By 
confocal microscopy we found VGLUT3 labelling within large astrocytic processes of 
the CA3 hippocampus and the frontal cortex, as well as Bergmann glia processes of 
the cerebellum. Using imunogold cytochemistry we found a significant level of 
VGLUT3 positive gold particles in astrocytic perisynaptic processes in these brain 
regions. The VGLUT3 gold particles were in most cases closer than 30 nm from 
synaptic-like microvesicles, although it was not the same population of synaptic-like 
microvesicles that were labelled for VGLUT1. These findings suggest that astrocytic 
processes in the above mentioned brain region have a subpopulation of synaptic-like 
microvesicles that can store glutamate due to the presence of VGLUT3. 
Paper III 
“GABA, but not bestrophin 1, is localised in astrocytic processes in the 
hippocampus and the cerebellum” 
In this article we studied the presence of GABA and bestrophin 1 in astrocytic 
processes. Both astrocytes from CA1 hippocampus and Bergmann glia from the 
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cerebellum showed GABA labelling with confocal microscopy. There was a higher 
density of GABA positive hippocampal astrocytes than cerebellar Bergmann glia in 
the confocal study. Although immunogold cytochemistry showed a significant level 
of GABA positive gold particles in hippocampal and cerebellar astroglia, the level of 
GABA was very low, approximately 0,3mM. The concentration of GABA was similar 
in hippocampal astrocytes and cerebellar Bergmann glia. 
Using confocal microscopy bestrophin 1 showed the same faint labelling of astrocytes 
and Bergmann glia in wild type and bestrophin 1 knockout brains. Western blots of 
brain tissue showed no significant bands neither in wild type nor bestrophin 1 
knockout tissue. There was, however, a band in the testis at the appropriate molecular 
weight. RT-PCR of hippocampus and cerebellum showed very low levels of 
bestrophin 1. These levels were equal to the level of bestrophin 1 mRNA in 
bestrophin 1 knockouts and were therefore considered to be background signals.  To 
conclude, we found that astroglia contain low, but significant, levels of GABA and 
that the level of bestrophin 1 in the brain is very low. This points to a release 
mechanism for GABA from astrocytes that do not involve bestrophin1. 
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DISCUSSION 
My results suggest that amino acid release from astrocytes can happen through 
regulated exocytosis. I show that astrocytes contain vesicles, resembling synaptic 
vesicles, and that they contain vesicular glutamate transporters, the VGLUTs. In 
search for proteins that can release amino acids by non-exocytotic mechanisms, I 
studied the localization of bestrophin 1 in the brain, without finding any firm evidence 
for its presence. 
Methodological considerations 
Immunocytochemistry is dependent on high sensitivity and selectivity of the 
antibodies to produce reliable results. The VGLUT1 and VGLUT3 antibodies used in 
the articles have high sensitivity, i.e. they strongly label glutamatergic asymmetric 
and GABAergic symmetric terminals, respectively. The selectivity is also high. The 
antibodies show only one band with appropriate molecular weight on western blots of 
brain tissue. Even if other proteins have the same molecular weight and the antibodies 
could theoretically cross-react and label totally different proteins, the selective 
labelling of “appropriate” structures in the brain tissue support the idea that the 
antibodies are selective. However, the most important tool to evaluate the selectivity 
of the astrocyte labelling is the knockout versus wild type comparison. The VGLUT3 
antibodies showed a very weak labelling of astrocytes in the VGLUT3 knockout, and 
a strong VGLUT3 labelling of astrocytes in wild type tissue, indicating that the 
VGLUT3 labelling of the astrocytes was highly selective. The VGLUT1 antibody did 
also produce one single band on Western blots of brain tissue. However, there was 
some immunogold labelling in the VGLUT1 knockout tissue, both in nerve terminals 
and in astrocytic processes, although the difference in VGLUT1 labelling between 
wild type and knockout tissue was significant. Concerning the findings in VGLUT1 
knockout and wild type they could be explained by two factors. Firstly, probably due 
to suboptimal perfusion fixation of the young mice, the tissue morphology of the 
VGLUT1 knockout and the wild type was of suboptimal quality. This gave a lower 
overall tissue labelling intensity than in rat tissue from the same brain structures and 
lead to a lower VGLUT1 labelling in astrocytes from wild type tissue. Secondly, we 
compared only VGLUT1 positive labelled structures in wild type and VGLUT1 
knockout. This difference is probably an underestimation of the true difference, as 
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there are more astrocytic processes devoid of VGLUT1 labelling in the knockout 
compared to the wild type. The experiment with preembedding immunoperoxidase 
histochemistry therefore better reflects the specificity of the VGLUT1 antibody. In 
this experiment the number of VGLUT1 positive astrocytic processes in VGLUT1 
knockout and wild type was counted in a comparative area. The experiment showed a 
high level of VGLUT1 positive astrocytic processes in wild type, while only a very 
few astrocytic processes contained VGLUT1 staining in the VGLUT1 knockout.  
The selectivity of the two bestrophin 1 antibodies from Marmorstein and Schreiber is 
a bit more intricate to evaluate due to the negative findings in my experiments and the 
sparse number of studies showing the location of bestrophin 1. However, the above 
mentioned antibodies both showed similar labelling patterns with dense labelling of 
astrocytic nuclei and a “spotted” labelling in the grey matter neuropil, with no distinct 
resemblance to any micro-anatomical structure. Moreover, both types of antibody 
showed weak and rather similar labelling of astrocytes in bestrophin 1 knockout and 
wild type brains. These findings indicate that the observed bestrophin 1 staining in the 
brain is unspesific. In further support of this is the finding on Western blots of brain 
tissue, which did not reveal any specific bestrophin1 band, but some “unspecific” 
bands, which were also present in Western blots of betrophin1 knockout brains.  
These “negative” results could be due to the possibility that the bestrophin 1 
antibodies not recognize the bestrophin 1 protein in the brain. However, both types of 
antibodies showed labelling of the retinal pigment epithelium and labelling that could 
represent Sertoli cells in the testis (Marmorstein et al, 2006; Petrukhin et al, 1998). 
They also gave a strong band at appropriate molecular weight on Western blots of 
testis tissue. Thus, the bestrophin 1antibodies used in the present thesis seem to 
recognize the bestrophin 1 protein. The sensitivity of the antibodies based on the 
confocal studies is difficult to interpret since the concentration of bestrophin 1 in 
retinal pigment epithelium and Sertoli cells have not been evaluated. Is the sensitivity 
of the antibodies too low to discover bestrophin 1 in the brain and particularly in 
astrocytes? From the work with the antibody based techniques in this thesis I cannot 
strictly rule out this possibility. Given a low sensitivity of the antibodies we wanted to 
detect bestrohin 1 with a method not depending on the use of antibodies. In this case 
we used real time PCR, which will be discussed later. 
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Confocal microscopy was used to evaluate qualitatively the VGLUT1, VGLUT3 and 
bestrophin 1 labelling in large astrocytic processes. The purpose of using confocal 
microscopy in the VGLUT1 and VGLUT3 study was mainly to support the findings 
of immunogold electron microscopy. Despite a low frequency of labelled astrocytes 
the high sensitivity and selectivity of the VGLUT1 and the VGLUT3 antibodies 
indicates that the fluorescence signals represent genuine astrocytic presence of 
VGLUT1 and VGLUT3. The lack of VGLUT1 labelling in the VGLUT1 KO mouse 
with the immunofluorescence method supports this notion. A low level of positive 
fluorescence labelling should always be interpreted carefully if using quantitative 
methods. Some quantitative colocalization methods could even be inappropriate, like 
Pearson’s correlation coefficient, depending on the proteins to be correlated. For 
instance Li et al 2013 used Pearson to evaluate the colocalization of S100β, a 
cytosolic protein, with VGLUT1, a vesicular protein. Since Pearson achieves the best 
correlation coefficient when the two fluorophores show the same intensity in the 
pixels they appear together, it is unlikely that a cytosolic and a vesicular protein will 
colocalize by this method. S100β and VGLUT1 belong to different compartments of 
the cell and their signal will not appear in the same pixels and as expected the 
Pearsons correlation coefficient will be low. There is not so much knowledge about 
unique astrocytic vesicular proteins and quantitative colocalization studies might 
seem difficult to accomplish. Besides, in whole tissue studies there always will be 
some noise. The noise, which is often a weak unspecific (not authentic) labelling, can 
easily mask the real labelling if the real labelling is rare, resulting in a non-correlation 
result (Bolte and Cordelieres, 2006). Schubert et al 2011 seemed to solve the 
abovementioned problems. However, this study had a more frequent labelling of 
tissue elements than represented in our VGLUT1 and VGLUT3 study. A final 
problem affecting VGLUT1 confocal experiments is that astrocytes are closely 
apposed to the abundantly expressed VGLUT1 terminals. The light from a 
fluorophore is spread concentrically and due to a low lateral resolution VGLUT1 
labelling in the terminal can falsely be seen at the border of adjacent small astrocytic 
processes. Deconvolution can partly solve this problem. However, since 
deconvolution removes some of the signal, it could be hard to know whether too 
much, to little or a proper amount of the signal is removed. Together, these were the 
reasons why we only examined the colocalization of VGLUT1 and GS in large 
astrocytic processes even after deconvolution. In the case of bestrophin 1, where the 
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labelling of bestrophin 1 knockout and wild type showed the same pattern and 
intensity in astrocytes and the brain tissue in general, we did not go any further with 
quantitative immunofluorescence or immunogold experiments. If there is a 
quantitative difference in the bestrophin 1 signal between the wild type and bestrophin 
1 KO tissue we would expect a clear visual difference between knockout and wild 
type tissue, like in the VGLUT1 immunoflourescence experiment. This was not the 
case for bestrophin 1.  
The immunogold method is suitable for quantitative measurements of proteins in 
small astrocytic processes. Small astrocytic processes are easily recognized due to 
their localization and their morphologic features. In rare occasions some spines can 
mimic small astrocytic processes. To avoid inclusion of spines, the tissue was labelled 
with GLT1/GLAST or glutamine synthetase to ensure that we included astrocytic 
processes in the analyses. The centre of a 10 nm gold particle could be approximately 
30 nm away from an antigen. Thus, gold particles found within perisynaptic astrocytic 
processes represent labelling of antigens within the astrocyte. The problem is to 
interpret in which type of astrocytic organelle the antigen is present. It could be 
located anywhere within the radius of about 30 nm in the horizontal or vertical plane. 
Finally, on the electron micrographs, although they are few, we find small vesicular 
like structures with approximately 30 nm in diameter. Over 90% of the VGLUT1 and 
VGLUT3 gold particles are below 30 nm away from the outline these vesicular 
structures, a strong indication that VGUT1 and VGLUT3 in astrocytes are located in 
the membrane of vesicular structures. These vesicular structures could be mistaken for 
transversely cut endoplasmatic reticulum, but we do not find VGLUT1 or VGLUT3 
in relation to any allantoid structure. In the rat immunogold study we analysed only 
astrocytic processes positive for VGLUT1 and VGLUT3. This selection was made 
because a substantial part of the processes probably lack VGLUTs (Bezzi et al, 2004) 
and we wanted to examine the level of VGLUTs in the VGLUT containing processes 
to that in e.g. excitatory nerve terminals. Inclusion of negative labelled astrocytic 
processes would falsely disturb this analysis. We also compared the positive labelled 
astrocytes with background labelling over mitochomdria and found that the density of 
VGLUT labelling in astrocytic processes was lower than in nerve terminals, but 
significantly higher than background labelling. Comparing only positive labelled 
astrocytes with a mixture of negative and positive labelled background mitochondrial 
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structures could seemingly give a false positive result. However, the true background 
labelling is given by both labelled and unlabelled profiles. Including only positive 
labelled background would give a falsely high background and not represent the 
actual background. Based on the present findings we do regard that the results in the 
rat brain represent a significant level of VGLUT1 and VGLUT3 and not false positive 
labelling. 
Quantitative real time PCR (qRT-PCR) is a highly sensitive method for detecting the 
RNA level from a specific gene (Wong and Medrano, 2005). As discussed above the 
bestrophin 1 antibodies showed low selectivity and their sensitivity was difficult to 
interpret. Due to its high sensitivity and selectivity qRT-PCR was a suitable method to 
test the uncertainty in the confocal experiments. As expected we found no evidence 
for bestrophin 1 RNA in the bestrophin 1 knockout tissue. In consistence with the 
confocal experiments this was also the case for the wild type tissue. The tissue used 
for the qRT-PCR was whole tissue from the cerebellar cortex, which consists of 
several cell types. If there are low levels of bestrophin 1 RNA in cerebellum the 
bestrophin 1 RNA could have been diluted and given a false negative result. 
However, in testis where bestrophin 1 is only present in Sertoli cells qRT-PCR 
showed a clear expression of bestrophin 1 RNA even if the number of Sertoli cells is 
low in comparison with for instance spermatocytes. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used to normalize the target gene. This gene has shown 
to be affected by treatments, biological processes and different tissues or cell types 
(Wong and Medrano, 2005). In this study GAPDH showed stable and nearly equal 
results in the cerebellum from bestrophin 1 knockout and wild type and testis wild 
type. A high level of GAPDH could therefore not explain the lack of bestrophin 1 
RNA in cerebellum. However, with the use of multiple housekeeping genes we could 
have been even more certain.    
Despite our many attempts we failed to reveal any significant signal for bestrophin 1 
RNA on qRT-PCR nor any bestrophin 1 protein on Western blots in brain. Confocal 
immunofluorescence experiments showed the same faint astrocytic staining in both 
wild type and bestrophin 1 knockout. Even if the selectivity of the antibodies was not 
optimal, the lack of bestrophin 1 RNA and protein and the lack of a clear cellular 
staining pattern truly support our final notion: there is no, or very low concentrations 
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of bestrophin 1 in astrocytes. Previous studies showing bestrophin 1 in astrocytes also 
showed release of GABA through bestrophin 1 (Lee et al, 2010). In our study we 
showed a very low level of astrocytic GABA. Some of the GABA is of course lost 
due to the fixation (up to 50%), but even if we make correction for this loss the level 
of GABA is still very low (Storm-Mathisen and Ottersen, 1990). GABA is both a 
weak acid and a weak base with an isoelectric point of 7.3 (Roberts and Sherman, 
1993). The cytosolic pH of astrocytes is somewhere between 7,0 and 7,2 (Brookes, 
1997). This indicates that GABA is slightly positive in astrocytic cytosol under 
physiological conditions. Bestrophin 1 however is an anion channel (Hartzell et al, 
2008). So the permeation of GABA through the bestrophin 1 channel will probably be 
very low. 
Is enough glutamate released from astrocytes to activate neuronal receptors? 
Even though it is estimated that a single synaptic vesicle contains about 10 VGLUT1 
or 2 transporters, and that the VGLUT copy number determines the vesicular 
glutamate content and release probability of glutamate at synapses, it has been shown 
that even a single VGLUT is enough to fill a vesicle with glutamate (Takamori et al, 
2006; Herman et al, 2014; Daniels et al, 2006). So, even the low levels of VGLUTs in 
astrocytes should be sufficient to fill astrocytic vesicles with glutamate. In astrocytes 
the vesicular accumulation of glutamate seems not to be dependent on the vesicular 
content of VGLUT1, but on that of VGLUT3. Overexpression of VGLUT3 led to 
increased astrocytic release of glutamate (Ni and Parpura, 2009). In addition, as is the 
case for synapses the intravesicular glutamate content in astrocytes can also be altered 
by the available concentration of glutamate in the cytosol (Ni and Parpura, 2009; 
Tabb et al, 1992). Moreover, the number and size of vesicles completing exocytosis 
and full fusion versus kiss and run is important for the glutamate level released into 
the gap between astrocytes and neurons (Harata et al, 2006; Chen et al, 2005). 
Neurons are equipped with a large cluster of synaptic vesicles in their nerve endings, 
while astrocytic processes only have scattered vesicles.  
This leaves us with the question: do astrocytes contain sufficient density of vesicles to 
release enough glutamate by exocytsis to have an impact on neuronal presynaptic 
NMDA receptors? 
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Theoretical glutamate level in astrocytic vesicles  
The driving force of glutamate uptake in vesicles are ΔΨ and ΔpH, together 
formulated ΔH+ (Tabb et al, 1992; Juge et al, 2006). To estimate the intravesicular 
glutamate level in astrocytes one can use Nernst equation: 
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F is the Faraday constant 96485,3399 C/mol. R is the gas constant 8,314 F is the 
Faraday constant 96485,3399 C/mol. R is the gas constant 8,3145 J/Kmol. T is the 
absolute temperature, here at 370 Celsius 310,15 K.   is the intra vesicular 
consentration of H+.   is the cytosolic concentration of H+. 
At chloride levels of 0 mM ΔΨ is the major driving force (Tabb et al, 1992). By using 
Nernst equation one can use the following formula to calculate the intra vesicular 
level of glutamate:  
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In astrocytes the   (cytosolic concentration of glutamate) is approximately 2 
mM (Gundersen et al 1998; Bergersen et al, 2012). Measurements of vesicular ΔΨ 
have varied between 0,05V and 0,125V (Russell 1984; Johnson and Scarpa, 1979; 
Shioi et al, 1989). Thus an estimation of intravesicular glutamate concentration can be 
done. What slightly complicates this is the presence of chloride. The level of 
intravesicular glutamate concentration increases with increasing level of cytosolic 
chloride until 4mM, where the vesicular glutamate concentration reaches its 
maximum (Tabb et al, 1992). Increasing the chloride level further will decrease the 
level of intra vesicular glutamate (Tabb et al, 1992). A second effect of increasing the 
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level of cytosolic chloride is a decrease of ΔΨ and an increase of ΔpH (Tabb et al, 
1992). Thereby a gradual changes in the driving force of vesicular glutamate uptake 
from ΔΨ to ΔpH (Tabb et al, 1992; Juge et al, 2006). Adding ΔpH in the Nernst 
equation gives us this formula: 
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Although the glutamate uptake seems not to correlate with the changes in ΔΨ and 
ΔpH according to the data presented by Tabb et al 1992 and Juge et al 2006. Nernst 
equation is not suitable for chloride levels other than 0 mM. Astrocytes have a 
chloride level about 40 mM (Walz, 2002). According to Tabb et al 1992 and Juge et al 
2006 vesicular glutamate uptake is 2-3 times higher at 40mM chloride than 0mM. Of 
course one has to be precocious to use the measurements in Tabb et al and Juge et al 
to make an estimation of intra vesicular glutamate concentration since there is a 
divergence between the two articles in the measurements of glutamate uptake not to 
ignore, especially at 4mM chloride. Although at 40mM chloride they seem relatively 
comparable.  
With ΔΨ=0,05V,  =2mM in the Nernst equation and doubling the result 
(40mM chloride), the lowest intra vesicular level of glutamate estimated is 26 mM. 
This fits with the estimated value of approximately 50 mM glutamate in astrocytic 
vesicles in the hippocampus (Bergersen et al, 2012). 
Activation of NMDA receptors 
With a vesicle diameter of 28 nm one glial vesicle can release 180 glutamate 
molecules (Bezzi et al, 2004): 
 

     
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L is Avogadros number (molecules pr mole), r is the vesicle radius and x is mole/L 
glutamate in vesicles. 
The study of Clements 1996 showed that one neuronal vesicle with 5000 glutamate 
molecules is enough to saturate the postsynaptic NMDA receptors. Holmes 1995 
estimated that 1000 to 4000 glutamate molecules saturate the NMDA receptors with 
16% to 81% respectively. More than 5500 glutamate molecules are necessary to 
saturate the NMDA receptors more than 90% (Holmes, 1995). Holmes 1995 
concludes that more than one neuronal vesicle is necessary to saturate the 
postsynaptic NMDA receptors. Thus astrocytes need to exocytose at least 31 vesicles 
to saturate an equal amount of NMDA receptors as found postsynaptic. It has been 
shown that one astrocytic process may contain clusters of 2-15 small synaptic-like 
microvesicles and that some processes can contain more than one cluster (Bergersen 
et al, 2012). In the study by Marchaland et al 2008 they report roughly 20 fusion 
events per 50 ms in an area of 6 μm2 when stimulated with 3,5-dihydrophenylglycine 
(an agonist of mGluR5). As 6 μm2 covers a bigger area than a perisynaptic astrocytic 
process it is not straightforward to estimate the number of fusion events in a 
perisynaptic process. However, when joining functional and structural findings it is 
likely that a perisynaptic astrocytic process can exocytose more than 31 vesicles 
(Marchaland et al, 2008; Bergersen et al, 2012). Full fusion of SLMVs from 
astrocytes will be able to saturate presynaptic NMDA receptors. Marchaland et al 
2008 found that astrocytic vesicles fuse partly by “kiss and run” (63%) and partly by 
full fusion (37%), while Chen et al 2005 claim they only fuse by “kiss and run” under 
physiological conditions. According to Staal et al 2004 small synaptic vesicles doing 
“kiss and run” release 25-30% of their contents. Thus astrocytic processes need to 
exocytose somewhere between 58 and122 vesicles in the kiss and run mode to 
saturate synaptic glutamate receptors. 58 vesicles are within range, but whether 122 
vesicular fusions from one astrocytic process can take place within a short time 
window (msec) is more doubtful, unless the vesicles can release their full content 
under “kiss and run” (like claimed by Stevens and Williams, 2000).   
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Physiological role of glutamate release from astrocytes 
Many studies have found that gliotransmitters can modulate long term potentiation 
(LTP) and synaptic plasticity. The mechanisms are diverse, and only the effect of 
astrocytic glutamate will be discussed here. One study showed that inhibition of 
calcium induced release of glutamate by astrocytes decreased the probability of 
neurotransmitter release and to an inhibition of spike-timing-dependent LTP (Bonasco 
et al, 2011). Perea and Araque 2007 and Jourdain et al 2007 also find that astrocytic 
glutamate release increases the probability of glutamate release in adjacent synapses. 
These studies indicate that astrocytic derived glutamate can trigger a short-term 
increase in synaptic plasticity. In addition, the former study discovered that when 
astrocytes released glutamate during postsynaptic depolarization the probability of 
neurotransmitter release where persistently increased and thereby induced a form of 
non-classical Hebbian LTP (Perea and Araque, 2007). Both presynaptic mGLuRs 
(Perea and Araque, 2007) and NMDA receptor 2B (Jourdain et al, 2007) seem to be 
involved in the potentiating effect of astrocytic glutamate release. Such a release has 
been shown to be induced by activity in pathways releasing ATP, endocannaboids or 
acetylcholine (Jourdain et al, 2007; Navarrete and Araque, 2010; Navarrete et al, 
2012). These differences could partly be explained by the fact that different brain 
regions display different mechanisms of astrocytic glutamate release. However, when 
LTP was discovered in experiments by Bliss and Lømo, 1973 they found that a 
cessation of tetanic stimulation of hippocampal pyramidal cells would make the cells 
capable of discharge on a single volley short time after the tetanic stimulation. Also 
taking the more general Hebbian LTP into account, the postsynaptic neuron need to 
fire immediately after the presynaptic neuron (spike-timing-dependent plasticity). 
This seems not to be a direct consequence of glutamate release from astrocytes. 
Hence, from classical LTP studies it is difficult to explain that glutamate release from 
astrocytes alone can induce LTP.  However, the studies by the group of Araque 
describe that glutamate from astrocytes can trigger a long lasting increase in the 
probability of neurotransmitter release, and thereby a long lasting increase of the 
amplitude of the postsynaptic potentials, which seem to be dependent on the temporal 
coincidence of postsynaptic activity and the release of glutamate from astrocytes.  
Extrasynaptic glutamate has been shown to activate presynaptic calmodulin 
dependent protein kinase II (CaMKII) and to have a possible role in long term 
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plasticity since it increases the frequency of spontaneous glutamate release and the 
number of presynaptic functional boutons for over 30 minutes (Ninan and Arancio, 
2004). Increased frequency of synaptic glutamate release has also shown to be the 
implication of astrocytic glutamate release and activation of presynaptic NMDA 
receptors (Jourdain et al, 2007). The phenomenon observed by Ninan and Arancio 
2004 could therefore be a consequence of astrocytic glutamate release.  
Probability of neurotransmitter release differs widely between terminals within CNS, 
even between terminals of the same axon and it is also adjustable (Branco and Staras, 
2009). Adjustment in the probability of neurotransmitter release could either be a 
short-term or a long-term event (Branco and Staras, 2009). In general, an adjustable 
probability of neurotransmitter release will contribute to regulate which synaptic 
inputs that would lead to a change in the neuronal output (Branco and Staras, 2009). 
One implication of this regulation could be to increase the signal to noise ratio. Since 
recovery from postsynaptic stimulation is energy-demanding, signal to noise ratio 
should be high to use as little energy as possible (Branco and Staras, 2009). Another 
implication of astrocyte regulation of activity at the level of a single synapse is that it 
allows terminals from one axon to be regulated individually, instead of a global 
regulation (Branco and Staras, 2009). Finally, the different probabilities of 
neurotransmitter release could be useful to regulate the importance of signals from 
different fibers (Branco and Staras, 2009). However, since the postsynaptic site also 
has a regulatory role on the probability of presynaptic neurotransmitter release, the 
contribution of astrocytic glutamate release is still rather unclear.  
Astrocytic exocytosis is also found to be involved in spike-timing dependent long-
term depression (t-LTD) in sensory neocortex (Min and Nevian, 2012). 
Endocannabinoids, which are thought to be released postsynaptically, can bind to 
cannabinoid receptors on perisynaptic astrocytes (Min and Nevian, 2012). This will 
induce a calcium elevation in the astrocyte and thereby exocytosis of astrocytic 
glutamate, which in turn will bind to presynaptic NMDA receptors and lead to t-LTP 
(Min and Nevian, 2012). The induced t-LTD was expressed as a presynaptic decrease 
in probability of transmitter release (Min and Nevian, 2012). However, the astrocytic 
induced t-LTD seems not to be a general principle for triggering LTD. In one study by 
Chevaleyre and Castillo 2003 they found that endocannaboids released from the 
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postsynaptic site activated endocannaboid receptors on the presynaptic terminal and 
thereby induced LTD in a NMDA receptor independent manner. The differences 
described above could be due to the possibility that different brain regions and 
synapse types use different mechanisms of inducing t-LTD (excitatory cerebral 
cortical synapses vs. hippocampal inhibitory synapses).  
As mentioned above glutamate release from astrocytes has a possible role in short 
term plasticity. Activation of astrocytic NMDA receptors will induce a presynaptic 
calcium influx (Jourdain et al, 2007; Zito and Scheuss, 2009; Bezzi et al, 2004). The 
increase in NMDA receptor mediated presynaptic calcium levels is not enough to 
induce fast and synchronous exocytosis of vesicles, but might be enough to have an 
impact on calcium sensitive proteins and thereby for example activate CaMKII or 
calcineurin. These proteins seem to modulate the function of several presynaptic 
proteins important for transmitter release.  
Vesicles and VGLUTs  
My finding of VGLUT containing vesicles in astrocytes from intact brain tissue is in 
agreement with previous electron microscopic findings (Bezzi et al, 2004; Stigliani et 
al, 2006).  Cultured astrocytes contain small (about 30-40 nm) and clear vesicles, 
which are positive for VGLUT (Stenovec et al, 2007; Martineau et al, 2013; Crippa et 
al, 2006). Although functional live imaging studies have not directly visualized 
vesicles, they have suggested that glutamatergic vesicles are present in astrocytes. 
From such studies in cultured astrocytes the size of the vesicles is estimated to vary 
between about 30-50 nm (Bowser and Khakh, 2007) and above 300 nm (Malarkey 
and Parpura, 2011; Chen et al, 2005). Even vesicles of several µm have been found in 
brain slice astrocytes, but these are produced by stimulating the astrocytes either 
mechanically or with high glutamate concentrations (Kang et al 2005; Xu et al 2007; 
Kang et al 2013; Peng et al 2013), suggesting that these vesicles are involved in 
release of gliotransmitters in pathological conditions (see below). 
Moreover, the results of the present thesis are in line with previous localization 
studies suggesting that the three vesicular glutamate transporters, VGLUT1, VGLUT2 
and VGLUT3, are all present in astrocytes. In cultured astrocytes VGLUT1, 2 and/or 
3 have been detected by immunohistochemistry (Bezzi et al, 2004; Montana et al, 
2004; Kreft et al, 2004; Zhang et al, 2004b; Anlauf and Derouiche, 2005; Crippa et al, 
 40 
2006; Bowser and Khakh, 2007; Stenovec et al, 2007; Marchaland et al, 2008; 
Potokar et al, 2009; Ni et al, 2009; Liu et al, 2011; Cali et al, 2014), and by reverse 
transcription polymerase chain reaction (rt-PCR) (Montana et al, 2004). It has been 
advocated that cultured cells can express proteins that normally are not expressed in 
cells in situ. This is probably not the case for VGLUTs in astrocytes, as they have all 
been found to be localized in acutely isolated astrocytes both at the protein  (Zhang et 
al, 2004b; Montana et al, 2004; Liu et al, 2011) and the mRNA (Zhang et al 2004b) 
level. In line with this are the present and previous immunohistochemical results, 
showing that VGLUT1, VGLUT2 and VGLUT3 are indeed located within delicate 
perisynaptic astrocytic processes in the intact brain (Paper 1 and 2; Fremeau et al, 
2002; Bezzi et al, 2004, Zhang et al, 2004b; Platel et al, 2010; Bergersen et al, 2012). 
In particular, the present thesis supports the findings of VGLUT3 in astrocytes. 
VGLUT3 have been shown to be upregulated in astrocytes after focal cerebral 
ischemia (Sánchez-Mendoza et al, 2010). In addition to astrocytes, retinal Muller cells 
have been shown to release glutamate by exocytosis of VGLUT3 containing secretory 
vesicles (Linnertz et al, 2011).  
In discordance to the above mentioned studies some studies do not find VGLUTs in 
astrocytes. By use of knock out controls for VGLUT1-3 one confocal study on 
cultured astrocytes and astrocytes in vivo shows that none of the VGLUTs are present 
in astrocytes (Li et al, 2013). In the present thesis the VGLUT1 and VGLUT3 
labelling in astrocytes were also controlled for by using VGLUT1 and VGLUT3 
knockout tissue. The discrepancies between the results of Li et al 2013 and mine are 
somewhat obscure. The main difference between the studies is that the first study used 
another type of VGLUT1 antibodies than used by me (while both studies used the 
same type of VGLUT3 antibodies). Li et al 2013 detected VGLUT localization in 
astrocytes by analyzing the intensity of the co-localization signal from VGLUTs and 
the astrocyte marker, while in the present thesis I directly detected VGLUT signals 
within astrocytic processes by analyzing several confocal planes, which spanned 
through entire processes of astrocytes. For a more thorough discussion of these 
findings, see above (Methodological considerations). 
Using microarray analysis two studies did not detect RNA transcripts for VGLUTs in 
isolated astrocytes from the mice brain (Cahoy et al, 2008). This is in contrast with 
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three previous studies detecting mRNA for VGLUTs in acutely isolated astrocytes by 
RT-PCR (Zhang et al, 2004b; Bezzi et al, 2004; Danik et al, 2005). 
Glutamate is released from astrocytes 
The presence of VGLUT containing small synaptic-like vesicles observed in my 
thesis is in line with the findings that astrocytes are competent of releasing glutamate 
from a vesicular compartment by regulated exocytosis. It should be noted that, besides 
the vesicular release of glutamate, release through anion channels is Ca2+ dependent 
(bestrohin 1:Sun et al, 2002; Kuo et al, 2014; VRACs: Mongin and Kimelberg, 2005). 
Thus, demonstrating Ca2+ dependent release of glutamate from astrocytes is probably 
not sufficient to conclude that astrocytes can release glutamate by exocytosis. 
Direct detection of glutamate released from astrocytes has mostly been performed in 
cultured astrocytes. Many such studies are consistent with a vesicular release 
mechanism of glutamate (Jeftinja et al, 1997; Bezzi et al, 1998; Bezzi et al, 2001; 
Pascual et al, 2001; Pasti et al, 2001; Bal-Price et al, 2002; Coco et al, 2003; Montana 
et al, 2004; Bezzi et al, 2004; Zhang et al, 2004b; Zhang et al, 2004; Domercq et al, 
2006; Cali et al, 2008; Höltje et al, 2008; Marchaland et al, 2008; Görg et al, 2010; 
Yaguchi and Nishizaki, 2010; Liu et al, 2011; Kanno and Nishizaki, 2012; Trkov et 
al, 2012; Cali et al, 2014 ). These reports do not only show that astrocytic glutamate 
release is Ca2+ dependent, but demonstrate that the glutamate release is sensitive to 
inhibition of various parts of the exocytotic release machinery in astrocytes. E.g. 
glutamate release was inhibited by the VGLUT inhibitors rose bengal/trypan blue, the 
vesicular H+-ATPase inhibitor bafilomycin A1 and SNARE protein cleavage by 
clostridium toxins. However, it has been suggested, that because cleavage of SNARE 
proteins could interfere with insertion of plasma membrane proteins, through which 
glutamate can be released (see below), the effect of clostridium toxins on glutamate 
release does not necessarily reflect vesicular release (Hamilton and Attwell, 2010). 
Therefore, the effect of blocking VGLUTs and the vesicular H+-ATPase is 
particularly important for concluding that the astrocytic release of glutamate is 
exocytotic. 
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Astrocytic VGLUTs and glutamate release under pathological conditions 
An excess of extracellular glutamate induces neuronal damage (Choi, 1988). 
VGLUTs in astrocytes have shown to be able to increase the vesicular uptake of 
glutamate when the amount of cytosolic glutamate increases (Ni and Parpura, 2009). 
Could VGLUTs play a protective role in cases with an excess of glutamate? 
Astrocytes scavenge extracellular glutamate via the excitatory amino acid 
transporters. Will then the VGLUTs contribute to further scavenging by storing 
glutamate in vesicles?  One study showed that application of extracellular glutamate 
or increasing cytosolic glutamate by blocking glutamate synthetase stimulated to 
formation of large vesicles (2-7μm) in astrocytes (Xu et al, 2007). The formation of 
the vesicles was due to uptake of glutamate by VGLUTs (Xu et al, 2007). However 
after 4-5 minutes the large vesicles fused with the astrocytic membrane and released 
their content (Xu et al, 2007). This could happen while another vesicle was filled with 
glutamate (Xu et al, 2007). This suggests that VGLUTs in astrocytes do not contribute 
to protect the neuron under conditions when the extracellular glutamate concentration 
is increased.glutamate.  
Epilepsy is a condition with periods of intensive bursts from a group of neurons. 
Astrocytes in CA1 hippocampus are in contact with approximate 140 000 synapses 
and may potentially have an impact on several synapses at the same time (Bushong et 
al, 2002). Due to this and the astrocytic influence on neurotransmission several 
studies have investigated whether astrocytes have a possible role in synchronized 
intensive bursts. One study found that in hippocampal slices, bathed in 4-
aminopyridine (giving action potential like membrane depolarizations), calcium 
oscillations in astrocytes mediated astrocytic glutamate release and thereby neuronal 
paroxysmal depolarization shifts (PDS) within 200μm (Tian et al, 2005). PDSs are 
described as: “abnormal prolonged depolarization with repetitive spiking 
characteristic of neurons in epileptic cortical zones that are reflected as interictal 
discharges in the electroencephalogram” (Rogawski and Löscher, 2004). PDS has 
been observed in several models of epileptogenesis (Curtis and Avanzini, 2001). 
Another study revealed that inositol 1,4,5-trisphosphate (IP3) injected into astrocytes 
induced glutamate release, which in turn triggered transient depolarizations in 
hippocampal pyramidal cells due to slowly decaying inward currents (Kang et al, 
2005). The transient depolarization reminded of PDS (Kang et al, 2005). In addition, 
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astrocytic astrocytic glutamate release also induced negative shift in field potential 
and possible synchronized activity, although these results relied on pathological high 
levels of astrocytic derived glutamate (Kang et al, 2005).  Gómez-Gonzalo et al 2010 
found that stimulating neurons with N-methyl-D-aspartic acid (NMDA) in entorhinal 
cortex slices, perfused with the proconvulsant 4-aminopyridine, evoked synchronized 
calcium elevation in a high number of astrocytes which contributed to ictal 
discharges. They proposed that the astrocytes recruited neurons into epileptic 
discharges (Gómez-Gonzalo et al, 2010). Interestingly, the calcium elevation of 
astrocytes had no role in propagation of ictal discharges outside the focal area and did 
not occur during interictal discharges (Gómez-Gonzalo et al, 2010). Epileptiform 
activity induced by picrotoxin and removal of external magnesium have been shown 
to increase the astrocytic glutamate release and thereby the frequency of neuronal 
slow inward currents (SICs) (Fellin et al, 2006). Astrocytes inducing SICs may lead to 
the generation of action potentials, however, they are not necessary for the generation 
epileptiform activity, although increased frequency of SICs might enhance the 
duration of epileptiform events (Fellin et al, 2006). These disparate findings make it 
unclear whether astrocytes actually can induce PDS.  
Besides, PDS is initiated by other mechanisms than by astrocytic release of glutamate, 
as for instance by dendritic activation (Altrup and Wiemann, 2003). Even if PDS is 
associated with epileptogenesis it seems not to generate seizures (Curtis and Avanzini, 
2001). A more active role for astrocytic glutamate release in propagating seizures 
seems unlikely, since astrocytes have a short range (μm) and there is a relative long 
latency from activation to glutamate release. In contrast, ictal activity is fast 
synchronized bursts with mm range.   
Studies have shown that NMDA receptors are important for survival of neuroblast and 
new neurons, mGLUR5 receptors have an impact on proliferation of neural precursor 
cells, while AMPA receptors may regulate the migratory process of newborn neuronal 
cells (Tashiro et al, 2006; Giorgi-Gerevini et al, 2005; Jansson et al, 2013; Platel et al, 
2010). The findings indicate a role for glutamate in neurogenesis. One study found an 
increased level of VGLUT2 and 3 in reactive astrocytes in ischemic corpus callosum 
and the perilesional cortex after brain ischemia (Sánchez-Mendoza et al, 2010). Thus 
astrocytic glutamate release might have a role in neurogenesis after brain ischemia. 
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